latest news

Kangstem Biotech selects MaSTherCell for GMP manufacturing

Kangstem Biotech, a biotechnology company specializing in developing cell therapies using mesenchymal stem cells derived from human umbilical cord blood, today announces the selection of MaSTherCell as its contract manufacturing partner for its European clinical trial of FURESTEM-AD. Discover the official press release here.